Prolonged heparin administration during clopidogrel treatment in healthy subjects

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue SUPPL. 2, 1999, Pages 61-64

  Caplain, Henri ^a   D'Honneur, Gaston ^a   Cariou, Roger ^b  

^a Hopital de la Fondation Cognacq Jay   (France)

^b SANOFI   (France)

Author keywords

Bleeding time; Clopidogrel; Clopidogrel heparin interaction; Heparin consumption; Platelet aggregation

Indexed keywords

CLOPIDOGREL; HEPARIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLEEDING TIME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG SAFETY; DRUG USE; HEART INFARCTION; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

ADENOSINE DIPHOSPHATE; ADMINISTRATION, ORAL; ADULT; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PARTIAL THROMBOPLASTIN TIME; TICLOPIDINE;

EID: 0032807806     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hirsh J. Drug therapy: Heparin. N Engl J Med 1991;324: 1565-1574
2. Théroux P, Fuster V. Acute coronary syndromes unstable angina and non-Q-wave myocardial infarction. Circulation 1998;97: 1195-1206
3. Verstraete M. Efficacité de l'association ticlopidine-aspirine dans la prévention de la thrombose subaiguuë sur endoprothèse coronaire. Sang Thrombose Vaisseaux 1996;8:471-473
4. Folts JD. Drugs for the prevention of coronary thrombosis: From an animal model to clinical trials. Cardiovasc Drugs Ther 1995;9:33-43
5. Eika C. Inhibition of thrombin-induced aggregation of human platelets by heparin. Scand J Haematol 1971;8:261-262
6. Born GRV. Quantitative investigation into the aggregation of blood platelets. J Physiol 1962;162:67P-68P
7. Ivy AC, Nelson D, Bucher G. The standardization of certain factors in the cutaneous "venostasis" bleeding time technique. J Lab Clin Med 1941;26:1812-1822
8. Schuirmann DJ. A comparison of the two one-sided procedure and the power approach for assessing equivalence of the average bioavailability. J Pharmacokin Biopharm 1987;15:657-690
9. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339
10. Monreal M, Lafoz E, Salvador R, Roncales J, Navarro A. Adverse effects of three different forms of heparin therapy: Thrombocytopenia, increased transaminases and hyperkalemia. Eur J Clin Pharmacol 1989;37:415-418